NasdaqGS - Nasdaq Real Time Price USD
Legend Biotech Corporation (LEGN)
34.42
-0.06
(-0.16%)
As of 1:06:43 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-144,033
-144,033
-393,276
-201,281
-198,465
Investing Cash Flow
-850,544
-850,544
92,786
-77,092
-194,983
Financing Cash Flow
5,698
5,698
791,490
377,976
626,663
End Cash Position
286,749
286,749
1,277,713
786,031
688,938
Capital Expenditure
-14,105
-14,105
-22,722
-22,275
-45,404
Issuance of Capital Stock
--
--
583,688
377,643
623,440
Repayment of Debt
-4,018
-4,018
-3,755
-2,596
-1,419
Free Cash Flow
-158,138
-158,138
-415,998
-223,556
-243,869
12/31/2021 - 6/5/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MRUS Merus N.V.
43.13
-0.19%
SRRK Scholar Rock Holding Corporation
32.93
+4.08%
ACLX Arcellx, Inc.
65.54
+3.83%
PTGX Protagonist Therapeutics, Inc.
46.28
+0.93%
ONC BeiGene, Ltd.
250.19
-1.02%
PTCT PTC Therapeutics, Inc.
49.65
+3.03%
FOLD Amicus Therapeutics, Inc.
7.05
+2.03%
GMAB Genmab A/S
20.13
-0.69%
ROIV Roivant Sciences Ltd.
10.80
+3.65%
PCVX Vaxcyte, Inc.
33.69
+7.76%